Dong Sung Bio Pharm.Co.,Ltd.
Szimbólum: 002210.KS
KSC
5240
KRWMai piaci árfolyam
-57.7739
P/E arány
-0.8344
PEG-arány
119.82B
MRK Cap
- 0.00%
DIV hozam
Dong Sung Bio Pharm.Co.,Ltd. (002210-KS) Pénzügyi kimutatások
Mérleg
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 21733.89 | 6435.4 | 4093.8 | 5142.8 | |||||||||||||||||
balance-sheet.row.short-term-investments | -3073.9 | 0 | 0 | 2002.6 | |||||||||||||||||
balance-sheet.row.net-receivables | 127499.54 | 31290.9 | 35361.6 | 29324.5 | |||||||||||||||||
balance-sheet.row.inventory | 72346.52 | 19477.1 | 14933.8 | 15519.1 | |||||||||||||||||
balance-sheet.row.other-current-assets | 16601.77 | 3611.5 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-current-assets | 238181.72 | 60814.9 | 54389.2 | 49986.3 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 172690.32 | 42725.5 | 43960.4 | 37377.8 | |||||||||||||||||
balance-sheet.row.goodwill | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.intangible-assets | 3645.02 | 978.8 | 855.8 | 942.7 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 3645.02 | 978.8 | 855.8 | 942.7 | |||||||||||||||||
balance-sheet.row.long-term-investments | 12525.06 | 7719.6 | 510.2 | -1606.9 | |||||||||||||||||
balance-sheet.row.tax-assets | 11078.52 | 0 | -510.2 | 17882 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 18636.95 | 2734.6 | 8496.6 | 0 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 218575.87 | 54158.4 | 53312.9 | 54595.6 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 456757.59 | 114973.3 | 107702.1 | 104581.9 | |||||||||||||||||
balance-sheet.row.account-payables | 47580.16 | 11261.1 | 8852 | 6858.8 | |||||||||||||||||
balance-sheet.row.short-term-debt | 112670.19 | 24732.5 | 29274 | 19714 | |||||||||||||||||
balance-sheet.row.tax-payables | 66.53 | 0 | 418.8 | 262.1 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 52132.34 | 18522.4 | 7761.9 | 9600.8 | |||||||||||||||||
Deferred Revenue Non Current | 17174.11 | 17.9 | 0 | 9113.3 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 10739.73 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 60212.7 | 8850.2 | 9183.7 | 3729.5 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 95537.15 | 30327.1 | 17321.6 | 20552.3 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 231.81 | 17.9 | 104.1 | 55.7 | |||||||||||||||||
balance-sheet.row.total-liab | 289693.7 | 75171 | 64892.8 | 58141.5 | |||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.common-stock | 104403.88 | 26101 | 26101 | 26101 | |||||||||||||||||
balance-sheet.row.retained-earnings | 4190.1 | -3006.9 | 1153.1 | -2570.8 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 11151.02 | 2787.8 | 2787.8 | 2787.8 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 47318.89 | 13920.5 | 12767.5 | 20122.4 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 167063.89 | 39802.3 | 42809.3 | 46440.4 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 456757.59 | 114973.3 | 107702.1 | 104581.9 | |||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-equity | 167063.89 | 39802.3 | 42809.3 | 46440.4 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 456757.59 | - | - | - | |||||||||||||||||
Total Investments | 9451.15 | 7719.6 | 510.2 | 395.7 | |||||||||||||||||
balance-sheet.row.total-debt | 164820.39 | 43272.8 | 37035.8 | 29314.8 | |||||||||||||||||
balance-sheet.row.net-debt | 147179.16 | 36837.4 | 32942 | 26174.6 |
Cash Flow kimutatás
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -2073.91 | -2073.9 | -2121.7 | -4312.8 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 2082.09 | 2046 | 2119.7 | 2222.6 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.change-in-working-capital | -5165.38 | -5165.4 | -4348.3 | -2543.3 | |||||||||||||||||
cash-flows.row.account-receivables | 2887.7 | 2887.7 | -4280.9 | -1791.5 | |||||||||||||||||
cash-flows.row.inventory | -3965.32 | -3965.3 | 629.7 | 4466.7 | |||||||||||||||||
cash-flows.row.account-payables | 1519.79 | 1519.8 | 1995 | -2870.6 | |||||||||||||||||
cash-flows.row.other-working-capital | -5607.55 | -5607.6 | -2692.1 | -2348 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 863.87 | 900 | 467.6 | 1882 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -4293.33 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -923.56 | -923.6 | -642.9 | -2323.5 | |||||||||||||||||
cash-flows.row.acquisitions-net | 32.78 | 18.2 | 74.3 | -197.7 | |||||||||||||||||
cash-flows.row.purchases-of-investments | -48.49 | -57.5 | -56.2 | -10994.9 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | -32.78 | 0 | 2019.9 | 14989.6 | |||||||||||||||||
cash-flows.row.other-investing-activites | 44.34 | 35.2 | -756.9 | -11173.2 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -927.71 | -927.7 | 638.3 | -9699.8 | |||||||||||||||||
cash-flows.row.debt-repayment | -33936.52 | -1229.6 | -44052.3 | -26435.5 | |||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 8455.4 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -1996.4 | -2990.4 | |||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | -8455.4 | |||||||||||||||||
cash-flows.row.other-financing-activites | 41503.88 | 8797 | 50289 | 30657.7 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 7567.35 | 7567.4 | 4240.2 | 1231.8 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -4.71 | -4.7 | -42.3 | 7.6 | |||||||||||||||||
cash-flows.row.net-change-in-cash | 2341.6 | 2341.6 | 953.6 | -11211.9 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 17641.23 | 6435.4 | 4093.8 | 3140.2 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 15299.63 | 4093.8 | 3140.2 | 14352.1 | |||||||||||||||||
cash-flows.row.operating-cash-flow | -4293.33 | -4293.3 | -3882.6 | -2751.5 | |||||||||||||||||
cash-flows.row.capital-expenditure | -923.56 | -923.6 | -642.9 | -2323.5 | |||||||||||||||||
cash-flows.row.free-cash-flow | -5216.9 | -5216.9 | -4525.5 | -5075.1 |
Eredménykimutatás sor
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 88593.59 | 88593.6 | 93328.2 | 84407.7 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 47447.64 | 47943.9 | 51272.8 | 50864 | |||||||||||||||||
income-statement-row.row.gross-profit | 41145.95 | 40649.6 | 42055.4 | 33543.6 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 4169.12 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 12376.07 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 24762.64 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | -20425.25 | -221 | 12200 | 12364.1 | |||||||||||||||||
income-statement-row.row.operating-expenses | 18666 | 40053.2 | 45152.4 | 38842.7 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 77055.41 | 87997.2 | 96425.2 | 89706.7 | |||||||||||||||||
income-statement-row.row.interest-income | 63.26 | 63.3 | 47.1 | 76.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 2240.91 | 2240.9 | 1307.8 | 712.2 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 24762.64 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -1462.29 | -1462.3 | 191.2 | 919.7 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | -20425.25 | -221 | 12200 | 12364.1 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | -1462.29 | -1462.3 | 191.2 | 919.7 | |||||||||||||||||
income-statement-row.row.interest-expense | 2240.91 | 2240.9 | 1307.8 | 712.2 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 12820.26 | 2046 | 2119.7 | 3980.6 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 13416.67 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | 596.4 | 596.4 | -2041.8 | -5299 | |||||||||||||||||
income-statement-row.row.income-before-tax | -865.89 | -865.9 | -1850.6 | -4379.3 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 1208.02 | 1208 | 271.1 | -66.5 | |||||||||||||||||
income-statement-row.row.net-income | -2073.91 | -2073.9 | -2121.7 | -4312.8 |
Gyakran ismételt kérdés
Mi a Dong Sung Bio Pharm.Co.,Ltd. (002210.KS) az összes eszköz?
Dong Sung Bio Pharm.Co.,Ltd. (002210.KS) az összes eszköz 114973284037.000.
Mekkora a vállalkozás éves bevétele?
Az éves bevétel 43786401591.000.
Mennyi a cég haszonkulcsa?
A cég haszonkulcsa 0.464.
Mennyi a vállalat szabad cash flow-ja?
A szabad pénzáramlás -228.151.
Mi a vállalati nettó haszonkulcs?
A nettó haszonkulcs -0.023.
Mennyi a vállalat teljes bevétele?
A teljes bevétel 0.007.
Mi a Dong Sung Bio Pharm.Co.,Ltd. (002210.KS) nettó profit (nettó nyereség)?
A nettó nyereség (nettó bevétel) -2073909512.000.
Mennyi a cég teljes adóssága?
Az összes adósság 43272811605.000.
Mi a működési költségek száma?
A működési költségek 40053242263.000.
Mennyi a cég készpénzállománya?
A vállalati pénzeszközök 6435381432.000.